Company attributes
Industry
Location
B2X
Number of Employees (Ranges)
11 – 50
Full Address
MEDICON VILLAGE SE-223, 81 LUND, Sweden, 0
CIK Number
Investors
Total Funding Amount (USD)
29,218,039
Latest Funding Round Date
August 2018
Latest Funding Type
Other attributes
Company Operating Status
Active
NeuroVive Pharmaceutical develops medicines for the treatment of primary mitochondrial diseases. The company is focused on two projects. KL1333, a NAD⁺ regulator and the US. NV354, an energy replacement (succinate) therapy.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.